cyanates has been researched along with Leucocythaemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, RP; Finch, RA; Penketh, PG; Ratner, ES; Sauro, R; Shyam, K | 1 |
| Adesida, A; Edwards, LG; Thornalley, PJ | 1 |
2 other study(ies) available for cyanates and Leucocythaemia
| Article | Year |
|---|---|
pH-dependent general base catalyzed activation rather than isocyanate liberation may explain the superior anticancer efficacy of laromustine compared to related 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine prodrugs.
Topics: Animals; Antineoplastic Agents; Catalysis; Cell Line, Tumor; DNA; Drug Design; Female; Half-Life; Humans; Hydrazines; Hydrogen-Ion Concentration; Isocyanates; Leukemia; Mice; Prodrugs; Protein Carbamylation; Sulfonamides; Transplantation, Homologous | 2018 |
Inhibition of human leukaemia 60 cell growth by mercapturic acid metabolites of phenylethyl isothiocyanate.
Topics: Acetylcysteine; Antineoplastic Agents; Cell Division; DNA; Humans; Isocyanates; Leukemia; Tumor Cells, Cultured | 1996 |